Is primary prevention of Clostridium difficile infection possible with specific probiotics?

Stuart Johnson, Pierre Jean Maziade, Lynne V. McFarland, William Trick, Curtis Donskey, Brian Currie, Donald E. Low, Ellie J C Goldstein

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: The efficacy of probiotics for the prevention of Clostridium difficile infection (CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We hypothesize that primary prevention of CDI among patients receiving antibiotics might be a more achievable goal for probiotics than prevention in patients with previous CDI where the host flora is markedly altered. Methods: We conducted a literature search for randomized, placebo-controlled efficacy studies of probiotic use among adults receiving antibiotics, in which CDI was one of the outcomes measured. In addition, we conducted meta-analyses of probiotics that were included in more than one randomized trial. Results: Eleven studies were identified; most were seriously underpowered to determine the efficacy of probiotics in the prevention of CDI. Two showed significantly lower rates of CDI among the probiotic recipients. A meta-analysis of three studies that used the probiotic combination Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R and a combined analysis of those studies with four studies that used Saccharomyces boulardii, showed lower CDI rates in recipients of probiotics compared with recipients of placebo (risk ratio = 0.39; 95% confidence interval 0.19-0.79). Conclusions: While potential flaws in study design were identified, a review of the available literature suggests that the primary prevention of CDI with specific probiotic agents may be achievable. Additional studies of sufficient size and with rigorous design are needed to confirm these findings.

Original languageEnglish (US)
JournalInternational Journal of Infectious Diseases
Volume16
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Clostridium Infections
Clostridium difficile
Probiotics
Primary Prevention
Meta-Analysis
Placebos
Anti-Bacterial Agents
Lactobacillus acidophilus
Lactobacillus casei
Odds Ratio
Confidence Intervals

Keywords

  • Antibiotic-associated diarrhea
  • CDI
  • Clostridium difficile
  • Prevention
  • Probiotics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Johnson, S., Maziade, P. J., McFarland, L. V., Trick, W., Donskey, C., Currie, B., ... Goldstein, E. J. C. (2012). Is primary prevention of Clostridium difficile infection possible with specific probiotics? International Journal of Infectious Diseases, 16(11). https://doi.org/10.1016/j.ijid.2012.06.005

Is primary prevention of Clostridium difficile infection possible with specific probiotics? / Johnson, Stuart; Maziade, Pierre Jean; McFarland, Lynne V.; Trick, William; Donskey, Curtis; Currie, Brian; Low, Donald E.; Goldstein, Ellie J C.

In: International Journal of Infectious Diseases, Vol. 16, No. 11, 11.2012.

Research output: Contribution to journalArticle

Johnson, S, Maziade, PJ, McFarland, LV, Trick, W, Donskey, C, Currie, B, Low, DE & Goldstein, EJC 2012, 'Is primary prevention of Clostridium difficile infection possible with specific probiotics?', International Journal of Infectious Diseases, vol. 16, no. 11. https://doi.org/10.1016/j.ijid.2012.06.005
Johnson, Stuart ; Maziade, Pierre Jean ; McFarland, Lynne V. ; Trick, William ; Donskey, Curtis ; Currie, Brian ; Low, Donald E. ; Goldstein, Ellie J C. / Is primary prevention of Clostridium difficile infection possible with specific probiotics?. In: International Journal of Infectious Diseases. 2012 ; Vol. 16, No. 11.
@article{c1af273f42d948239bcdbae756c1e89c,
title = "Is primary prevention of Clostridium difficile infection possible with specific probiotics?",
abstract = "Background: The efficacy of probiotics for the prevention of Clostridium difficile infection (CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We hypothesize that primary prevention of CDI among patients receiving antibiotics might be a more achievable goal for probiotics than prevention in patients with previous CDI where the host flora is markedly altered. Methods: We conducted a literature search for randomized, placebo-controlled efficacy studies of probiotic use among adults receiving antibiotics, in which CDI was one of the outcomes measured. In addition, we conducted meta-analyses of probiotics that were included in more than one randomized trial. Results: Eleven studies were identified; most were seriously underpowered to determine the efficacy of probiotics in the prevention of CDI. Two showed significantly lower rates of CDI among the probiotic recipients. A meta-analysis of three studies that used the probiotic combination Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R and a combined analysis of those studies with four studies that used Saccharomyces boulardii, showed lower CDI rates in recipients of probiotics compared with recipients of placebo (risk ratio = 0.39; 95{\%} confidence interval 0.19-0.79). Conclusions: While potential flaws in study design were identified, a review of the available literature suggests that the primary prevention of CDI with specific probiotic agents may be achievable. Additional studies of sufficient size and with rigorous design are needed to confirm these findings.",
keywords = "Antibiotic-associated diarrhea, CDI, Clostridium difficile, Prevention, Probiotics",
author = "Stuart Johnson and Maziade, {Pierre Jean} and McFarland, {Lynne V.} and William Trick and Curtis Donskey and Brian Currie and Low, {Donald E.} and Goldstein, {Ellie J C}",
year = "2012",
month = "11",
doi = "10.1016/j.ijid.2012.06.005",
language = "English (US)",
volume = "16",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Is primary prevention of Clostridium difficile infection possible with specific probiotics?

AU - Johnson, Stuart

AU - Maziade, Pierre Jean

AU - McFarland, Lynne V.

AU - Trick, William

AU - Donskey, Curtis

AU - Currie, Brian

AU - Low, Donald E.

AU - Goldstein, Ellie J C

PY - 2012/11

Y1 - 2012/11

N2 - Background: The efficacy of probiotics for the prevention of Clostridium difficile infection (CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We hypothesize that primary prevention of CDI among patients receiving antibiotics might be a more achievable goal for probiotics than prevention in patients with previous CDI where the host flora is markedly altered. Methods: We conducted a literature search for randomized, placebo-controlled efficacy studies of probiotic use among adults receiving antibiotics, in which CDI was one of the outcomes measured. In addition, we conducted meta-analyses of probiotics that were included in more than one randomized trial. Results: Eleven studies were identified; most were seriously underpowered to determine the efficacy of probiotics in the prevention of CDI. Two showed significantly lower rates of CDI among the probiotic recipients. A meta-analysis of three studies that used the probiotic combination Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R and a combined analysis of those studies with four studies that used Saccharomyces boulardii, showed lower CDI rates in recipients of probiotics compared with recipients of placebo (risk ratio = 0.39; 95% confidence interval 0.19-0.79). Conclusions: While potential flaws in study design were identified, a review of the available literature suggests that the primary prevention of CDI with specific probiotic agents may be achievable. Additional studies of sufficient size and with rigorous design are needed to confirm these findings.

AB - Background: The efficacy of probiotics for the prevention of Clostridium difficile infection (CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We hypothesize that primary prevention of CDI among patients receiving antibiotics might be a more achievable goal for probiotics than prevention in patients with previous CDI where the host flora is markedly altered. Methods: We conducted a literature search for randomized, placebo-controlled efficacy studies of probiotic use among adults receiving antibiotics, in which CDI was one of the outcomes measured. In addition, we conducted meta-analyses of probiotics that were included in more than one randomized trial. Results: Eleven studies were identified; most were seriously underpowered to determine the efficacy of probiotics in the prevention of CDI. Two showed significantly lower rates of CDI among the probiotic recipients. A meta-analysis of three studies that used the probiotic combination Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R and a combined analysis of those studies with four studies that used Saccharomyces boulardii, showed lower CDI rates in recipients of probiotics compared with recipients of placebo (risk ratio = 0.39; 95% confidence interval 0.19-0.79). Conclusions: While potential flaws in study design were identified, a review of the available literature suggests that the primary prevention of CDI with specific probiotic agents may be achievable. Additional studies of sufficient size and with rigorous design are needed to confirm these findings.

KW - Antibiotic-associated diarrhea

KW - CDI

KW - Clostridium difficile

KW - Prevention

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=84868195398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868195398&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2012.06.005

DO - 10.1016/j.ijid.2012.06.005

M3 - Article

VL - 16

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 11

ER -